Clinical Trials Phase II & III

Clinical Trials Phase II & III Training: From Proof of Concept to Pivotal Evidence

Phase II and III trials generate the evidence that wins or loses market authorization. Errors in protocol design, data management, or trial master file governance can invalidate years of work in a single inspection. This certified online learning path for Phase 2 and 3 clinical trials, developed under the expert guidance of Dr. Patricia Kay, gives clinical research professionals the full operational and regulatory toolkit to design, manage, and deliver pivotal studies that meet ICH-GCP E6(R3) standards and withstand FDA and EMA inspection.

Course Breakdown:

• Clinical Trial Protocol: Master the structure, content, and regulatory requirements of the protocol that governs every decision in a Phase II or III study.
• Randomization & Blinding in Clinical Research Trials: Understand the statistical and operational principles of randomization and blinding and their critical role in trial validity.
• Clinical Data Management: Learn the end-to-end process of collecting, validating, and managing clinical data to ensure ALCOA+ compliance across multi-site studies.
• Clinical Trials: Preparing for an Audit or Inspection: Build the inspection-ready mindset and practical skills needed to navigate sponsor audits and regulatory inspections.
• Management of the TMF and ISF: Maintain your Trial Master File and Investigator Site File to the standard required by ICH E6(R3) and regulatory inspectors throughout the trial lifecycle.
• ICH-GCP: Introduction to Good Clinical Practice: Reinforce the foundational GCP principles that underpin every aspect of Phase II and III trial conduct.
• GCP Refresher 2026: ICH-GCP E6(R3) Revision: Apply the most recent GCP updates to your late-phase operations and documentation practices.

Why Choose This Learning Path?

• Expert-Led Curriculum: Developed by Dr. Patricia Kay, a senior research management leader with 20+ years of clinical development experience across cardiovascular, immunology, and infectious disease programs.
• End-to-End Coverage: From protocol design and randomization through data management, TMF governance, and inspection readiness, every operational pillar of late-phase trials.
• Flexible Learning: Fully self-paced and online. Study around active trial commitments and revisit modules as regulatory guidance updates.
• Recognized Certification: Earn a CPD/CEU-accredited, 21 CFR Part 11-compliant certificate validating your Phase II/III competency to sponsors, ethics committees, and regulators.

What You’ll Be Able to Do

• Design protocols and randomization schemes for Phase II and III trials.
• Govern clinical data management and TMF/ISF processes to ICH E6(R3) standards.
• Prepare your site or sponsor organization for FDA and EMA inspections.
• Apply the E6(R3) changes across active trial operations.

Who Should Enroll?

Whether you are a clinical research associate, trial manager, data manager, TMF specialist, or regulatory professional transitioning into late-phase operations, this learning path was built for you. It is equally valuable for pharmaceutical and CRO teams standardizing clinical operations training across pivotal trial portfolios.

Deliver the Evidence That Brings Medicines to Patients

GxP Training delivers certified, employer-recognized training to life sciences professionals worldwide. Phase II and III trials are where reputations and drug programs are made or broken. Enroll today and build the skills pivotal trials demand.